Back to results
US 2015/0148374 A1Published application
Complement pathway modulators and uses thereof
AssigneeNovartis AG
InventorsUlrich Hommel, Edwige Liliane Jeanne Lorthiois, Jeurgen Klaus Maibaum, Nils Ostermann, Stefan Andreas Randl, Olivier Rogel, Anna Vulpetti
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Claims17
A compound or a salt thereof according to Formula I:
- wherein
- A is a group selected from:
- Z1 is C(R1) or N;
- Z2 is C(R2) or N;
- Z3 is C(R3) or N, wherein at least one of Z1, Z2 or Z3 is not N;
- R1 is selected from the group consisting of hydrogen, halogen, C1-C6alkyl, C1-C6alkoxy, haloC1-C6alkyl, haloC1-C6alkoxy C1-C6alkoxycarbonyl, CO2H and C(O)NRARB;
- R2 and R3 are independently selected from the group consisting of hydrogen, halogen, hydroxy, NRCRD, cyano, CO2H, CONRARB, SO2C1-C6alkyl, and SO2NH2, SO2NRARB, C1-C6alkoxycarbonyl, —C(NRA)NRCRD, C1-C6alkyl, C3-C6cycloalkyl, haloC1-C6alkyl, C2-C6alkenyl, C1-C6alkoxy, haloC1-C6alkoxy, C2-C6alkenyloxy, wherein each alkyl, alkenyl, alkoxy and alkenyloxy is unsubstituted or substituted with up to 4 substitutents independently selected from halogen, hydroxy, cyano, tetrazole, C1-C4alkoxy, C1-C4haloalkoxy, CO2H, C1-C6alkoxycarbonyl, C(O)NRARB, NRCRD, optionally substituted phenyl, heterocycle having 4 to 7 ring atoms and 1, 2, or 3 ring heteroatoms selected from N, O or S, heteroaryl having 5 or 6 ring atoms and 1 or 2 or 3 ring heteroatoms selected from N, O or S, and wherein optional phenyl and heteroaryl substituents are selected from halogen, hydroxy, C1-C4alkyl, C1-C4alkoxy and CO2H;
- R5 is C1-C4alkyl, hydroxyC1-C4alkyl, haloC1-C4alkyl, C1-C4alkoxyC1-C4alkyl, amino, methylamino;
- X1 is CR9R22 or sulfur;
- X2 is CR7R8, oxygen, sulfur, N(H) or N(C1-C6alkyl), wherein at least one of X1 and X2 is carbon;
- or
- X1 and X2, in combination, forms an olefin of the formula —C(R7)═C(H)— or —C(R7)═C(C1-C4alkyl)-, wherein the C(R7) is attached to X3;
- X3 is (CR6R21)q or N(H) wherein q is 0, 1 or 2, wherein X3 is CR6R21 or (CR6R21)2 when either X1 or X2 is sulfur or X2 is oxygen;
- or
- X2 and X3, taken in combination, are —N═C(H)— or —N═C(C1-C4alkyl)- in which the C(H) or C(C1-C4alkyl) is attached to X1;
- R6 is selected at each occurrence from hydrogen and C1-C6alkyl;
- R7 is hydrogen, halogen, hydroxy, cyano, C1-C6alkyl, C1-C6alkoxy, hydroxyC1-C6alkyl, C1-C6alkoxyC1-C6alkyl, haloC1-C6alkyl, or C1-C6haloalkoxy;
- R8 is hydrogen, halogen, hydroxy, azide, cyano, COOH, C1-C6alkoxycarbonyl, C1-C6alkyl, C1-C6alkoxy, C1-C6haloalkyl, C1-C6haloalkoxy, NRARB, N(H)C(O)C1-C6alkyl, hydroxyC1-C6alkyl, C1-C6alkoxyC1-C6alkyl, or C1-C6alkyl substituted with NRARB, N(H)C(O)H or N(H)C(O)(C1-C4alkyl);
- R9 is selected from the group consisting of hydrogen, hydroxy, halogen, C1-C6alkyl, haloC1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkoxy, haloC1-C6alkoxy, NRARB, N(H)C(O)C1-C6alkyl, N(H)C(O)OC1-C6alkyl and OC(O)NRCRD each of alkyl, alkoxy, alkenyl, and alkynyl substituents may be substituted with 0, 1, or 2 groups independently selected at each occurrence from the group consisting of halogen, hydroxy, C1-C6alkyl, C1-C6alkoxy, and NRARB;
- R20 is hydrogen or C1-C6alkyl;
- R21 is selected at each occurrence from the group consisting of hydrogen, phenyl and C1-C6alkyl, which alkyl group is unsubstituted or substituted with hydroxy, amino, azide, and NHC(O)C1-C6alkyl;
- R22 is selected from the group consisting of hydrogen, halogen, hydroxy, amino and C1-C6alkyl;
- CR7R8, taken in combination forms a spirocyclic 3 to 6 membered carbocycle which is substituted with 0, 1, or 2 substituents independently selected from the group consisting of halogen and methyl;
- or
- R7 and R8, taken in combination, form an exocyclic methylidene (═CH2);
- R7 and R22 or R8 and R9, taken in combination form an epoxide ring or a 3 to 6 membered carbocyclic ring system which carbocyclic ring is substituted with 0, 1, or 2 substituents independently selected from the group consisting of halogen, methyl, ethyl, hydroxyC1-C4alkyl, C1-C6alkoxyC1-C4alkyl, C1-C4alkoxycarbonyl, CO2H, and C1-C4alkyl substituted with NRARB;
- R6 and R7 or R8 and R21, taken in combination, form a fused 3 membered carbocyclic ring system which is substituted with 0, 1 or 2 substituents independently selected from the group consisting of halogen, methyl, ethyl, hydroxyC1-C4alkyl, C1-C6alkoxyC1-C4alkyl, C1-C4alkoxycarbonyl, CO2H, and C1-C4alkyl substituted with NRARB;
- or
- R20 and R22 taken in combination form a fused 3 carbocyclic ring system;
- R9 and R21 taken in combination form a form 1 to 3 carbon alkylene linker;
- R7 and R20 taken in combination form 1 to 3 carbon alkylene linker;
- R10 is C1-C4alkyl, C3-C6cycloalkyl, C3-C6cycloalkylC1-C4alkyl, or haloC1-C3alkyl;
- W1 is C(R11) or N;
- W2 is C(R12) or N;
- W3 is C(R13) or N;
- R11 and R13 are independently selected from the group consisting of hydrogen, halogen, C1-C6alkyl;
- R12 is hydrogen, halogen, C1-C4alkyl, C3-C7cycloalkyl, C1-C4alkoxy, C1-C4haloalkyl, cyano, hydroxy, CO2H, CO2Me, CONRARB or phenyl;
- RA and RB are independently selected from the group consisting of hydrogen, and C1-C6alkyl, haloC1-C6alkyl, C1-C6alkoxyC1-C6alkyl, hydroxyC1-C6alkyl, or NRARB, taken in combination, form a heterocycle having 4 to 7 ring atoms and 0 or 1 additional ring N, O or S atoms, which heterocycle is substituted with 0, 1, or 2 substituents independently selected from the group consisting of C1-C4alkyl, halogen, hydroxy, C1-C4alkoxy;
- and
- RC and RD, are each independently selected from the group consisting of hydrogen and C1-C6alkyl, haloC1-C6alkyl, C1-C6alkoxyC1-C6alkyl, or hydroxyC1-C6alkyl.
37 more elements
A compound or a salt thereof according to Formula II:
- wherein
- A is a group selected from:
- Z1 is C(R1) or N;
- Z2 is C(R2) or N;
- Z3 is C(R3) or N, wherein at least one of Z1, Z2 or Z3 is not N;
- R1 is selected from the group consisting of hydrogen, halogen, C1-C6alkyl, C1-C6alkoxy, haloC1-C6alkyl, haloC1-C6alkoxy C1-C6alkoxycarbonyl, CO2H and C(O)NRARB;
- R2 and R3 are independently selected from the group consisting of hydrogen, halogen, hydroxy, NRCRD, cyano, CO2H, CONRARB, SO2C1-C6alkyl, and SO2NH2, SO2NRARB, C1-C6alkoxycarbonyl, —C(NRA)NRCRD, C1-C6alkyl, C3-C6cycloalkyl, haloC1-C6alkyl, C2-C6alkenyl, C1-C6alkoxy, haloC1-C6alkoxy, C2-C6alkenyloxy, wherein each alkyl, alkenyl, alkoxy and alkenyloxy is unsubstituted or substituted with up to 4 substitutents independently selected from halogen, hydroxy, cyano, tetrazole, C1-C4alkoxy, C1-C4haloalkoxy, CO2H, C1-C6alkoxycarbonyl, C(O)NRARB, NRCRD, optionally substituted phenyl, heterocycle having 4 to 7 ring atoms and 1, 2, or 3 ring heteroatoms selected from N, O or S, heteroaryl having 5 or 6 ring atoms and 1 or 2 or 3 ring heteroatoms selected from N, O or S, and wherein optional phenyl and heteroaryl substituents are selected from halogen, hydroxy, C1-C4alkyl, C1-C4alkoxy and CO2H;
- R5 is C1-C4alkyl, hydroxyC1-C4alkyl, haloC1-C4alkyl, C1-C4alkoxyC1-C4alkyl, amino, methylamino;
- R6 is hydrogen;
- R7 is hydrogen or fluoro;
- R8 is hydrogen, methyl or hydroxymethyl;
- R9 is hydrogen, halogen, hydroxy or C1-C4alkoxy;
- or
- R6 and R7, taken in combination, form a cyclopropane ring;
- or
- R8 and R9, taken in combination, form a cyclopropane ring;
- R10 is C1-C4alkyl, C3-C6cycloalkyl-methyl or haloC1-C3alkyl;
- W1 is C(R11) or N;
- W2 is C(R12) or N;
- W3 is C(R13) or N;
- R11 and R13 are independently selected from the group consisting of hydrogen, halogen, C1-C6alkyl;
- R12 is hydrogen, halogen, C1-C4alkyl, C3-C7cycloalkyl, C1-C4alkoxy, C1-C4haloalkyl, cyano, hydroxy, CO2H, CO2Me, CONRARB or phenyl;
- RA and RB are independently selected from the group consisting of hydrogen, and C1-C6alkyl, haloC1-C6alkyl, C1-C6alkoxyC1-C6alkyl, hydroxyC1-C6alkyl, or NRARB, taken in combination, form a heterocycle having 4 to 7 ring atoms and 0 or 1 additional ring N, O or S atoms, which heterocycle is substituted with 0, 1, or 2 substituents independently selected from the group consisting of C1-C4alkyl, halogen, hydroxy, C1-C4alkoxy;
- and
- RC and RD, are each independently selected from the group consisting of hydrogen and C1-C6alkyl, haloC1-C6alkyl, C1-C6alkoxyC1-C6alkyl, or hydroxyC1-C6alkyl.
22 more elements
14-15. (canceled)
18-22. (canceled)
Dependencies are inferred from the claim text.